A new preprint discusses how novel tuberculosis vaccines for adolescents and adults could mitigate this problem.
Psilocybin by Filament Health for Treatment Resistant Depression: Likelihood of Approval
Psilocybin is under clinical development by Filament Health and currently in Phase I for Treatment Resistant Depression.